Correlation Between CO2 Energy and Drugs Made
Can any of the company-specific risk be diversified away by investing in both CO2 Energy and Drugs Made at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CO2 Energy and Drugs Made into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CO2 Energy Transition and Drugs Made In, you can compare the effects of market volatilities on CO2 Energy and Drugs Made and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CO2 Energy with a short position of Drugs Made. Check out your portfolio center. Please also check ongoing floating volatility patterns of CO2 Energy and Drugs Made.
Diversification Opportunities for CO2 Energy and Drugs Made
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between CO2 and Drugs is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding CO2 Energy Transition and Drugs Made In in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Drugs Made In and CO2 Energy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CO2 Energy Transition are associated (or correlated) with Drugs Made. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Drugs Made In has no effect on the direction of CO2 Energy i.e., CO2 Energy and Drugs Made go up and down completely randomly.
Pair Corralation between CO2 Energy and Drugs Made
Assuming the 90 days horizon CO2 Energy is expected to generate 1.54 times less return on investment than Drugs Made. In addition to that, CO2 Energy is 2.17 times more volatile than Drugs Made In. It trades about 0.04 of its total potential returns per unit of risk. Drugs Made In is currently generating about 0.14 per unit of volatility. If you would invest 996.00 in Drugs Made In on February 3, 2025 and sell it today you would earn a total of 12.00 from holding Drugs Made In or generate 1.2% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 76.56% |
Values | Daily Returns |
CO2 Energy Transition vs. Drugs Made In
Performance |
Timeline |
CO2 Energy Transition |
Drugs Made In |
CO2 Energy and Drugs Made Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CO2 Energy and Drugs Made
The main advantage of trading using opposite CO2 Energy and Drugs Made positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CO2 Energy position performs unexpectedly, Drugs Made can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Drugs Made will offset losses from the drop in Drugs Made's long position.CO2 Energy vs. Enersys | CO2 Energy vs. Cosan SA ADR | CO2 Energy vs. ERecord Management | CO2 Energy vs. Kite Realty Group |
Drugs Made vs. US GoldMining Common | Drugs Made vs. Simon Property Group | Drugs Made vs. Tradeshow Marketing | Drugs Made vs. Insteel Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |